Endpoints News 生物医药· Ayisha Sharma·· 15 天前AI 评分33
Alethio 筹集 9000 万美元推进 Essential Thrombocythemia 抗体药物开发
Alethio clinches $90M to advance antibody for essential thrombocythemia
AI 导读
Alethio Therapeutics 筹集 9000 万美元用于推进 Essential Thrombocythemia 抗体药物开发。公司于一年前从隐身模式中 emerge。
正文
About a year after emerging from stealth, University of Oxford spinout Alethio Therapeutics has collected $90 million in a Series A …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news